Literature DB >> 481454

Sister-chromatid exchanges and chromosal breakage in patients treated with cytostatics.

J Musilová, K Michalová, J Urban.   

Abstract

The frequency of structural chromosomal rearrangements and sister-chromatid exchanges (SCEs) was investigated in short-term phytohemagglutininstimulated lymphocyte cultures by means of bromodeoxyuridine substitution and fluorescence plus Giemsa (FPG) staining technique. Both these parameters were significantly increased in patients treated with comparatively low doses of cyclophosphamide, busulphan and adriamycin. The increased SCE rate was proportional to the number of chromosome breaks, the ratio of SCE to breaks being about 100:1. The increase in the SCE number was maintained for several months after the termination of cytostatic therapy, when the conventional analysis of chromosome breaks yielded normal results. Normal SCE values were obtained in two patients treated with low doses of fluorouracil.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 481454     DOI: 10.1016/0165-1218(79)90023-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.

Authors:  I Stucker; A Hirsch; T Doloy; I Bastie-Sigeac; D Hemon
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

2.  Increasing rates of DNA single-strand breaks in lymphocytes of clinical personnel handling cytostatic drugs.

Authors:  M Reitz; S Afghanyar; P Gutjahr
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 3.  Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.

Authors:  E Gebhart
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Chromosome studies on lymphocytes of patients under cytostatic therapy. I. Conventional chromosome studies in cytostatic interval therapy.

Authors:  E Gebhart; J Lösing; F Wopfner
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

5.  Chromosome studies on lymphocytes of patients under cytostatic therapy. II. Studies Using the BUDR-labelling technique in cytostatic interval therapy.

Authors:  E Gebhart; B Windolph; F Wopfner
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

6.  Sister chromatid exchange-inducing DNA lesions and depression of activation markers on the surface of cultured peripheral blood mononuclear cells after the addition of streptococcal pyrogenic exotoxins A and C.

Authors:  A Büssing; M Klotz; K Suzart; T Efferth; D Gerlach; N Schnitzler; R Osieka; K Schweizer; A Kaufhold
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

Review 7.  Chromosomal methods in population studies.

Authors:  M K Conner; N Wald
Journal:  Environ Health Perspect       Date:  1981-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.